Skip to main content
. 2019 May 3;46(1):98–109. doi: 10.1093/schbul/sbz038

Table 2.

Relapse Rates of Studies Included in the Meta-analysis

Study Nº (FIG/CG) Relapse Criteria Relapse Rates n/N (%) Decrease in Relapse
Zhang et al. (1994) FIG: 32
CG: 31
Hospitalization FIp: 5/32 (15.4%)
CG: 17/31 (53.8%)
Significant
Linszent et al. (1996) FIG: 37
CG: 39
Relapse defined as: (1) recurrent or exacerbated psychotic symptoms explicitly recorded in psychiatric notes; (2) a significant increase in antipsychotic medication; and (3) psychotic symptoms persisting for at least 1 wk. All 3 criteria must be present FIp: 10/37 (27%)
CG: 18/39 (50%)
Not significant
Leavey et al. (2004) FIG: 57
CG: 49
Hospitalization FIp: 6/57 (10.52%)
CG: 6/49 (12.24%)
Not significant
Gleeson et al. (2010, 2013) FIG: 41
CG: 40
Ratings from 3 (mild) or below increasing to 6 or 7 (severe and very severe) on any of the following 3 BPRS* items: (1) unusual thought content, (2) hallucinations, and (3) conceptual disorganization, meeting 1-wk duration criterion 7 mo, FIp: 2/34 (5.9%)
CG: 8/37 (21.6%)
30 mo, FIp: 9/30 (30%)
CG: 13/30 (43.3%)
Significant
Not significant
Palma-Sevillano et al (2011) FIG: 21
CG:13
Hospitalization FIp: 4/21 (19%)
CG: 9/13 (69.2%)
Not significant
Calvo et al (2014, 2015) FIG: 27
CG: 25
Hospitalization FIp: 4/27 (13%)
CG: 12/25(50%)
Not significant

Note: BPRS, Brief Psychiatric Rating Scale; CG, comparison group; FIF, family intervention group; FIp, family intervention for psychosis.